These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pathogenesis of so-called thrombotic microangiopathy of the kidneys (hemolytic uremic syndrome) based on early-stage morphological studies]. John HD, Thoenes W. Verh Dtsch Ges Pathol; 1978; 62():521. PubMed ID: 746960 [No Abstract] [Full Text] [Related]
3. Recurrence of the hemolytic uremic syndrome in a 3 1/2-year-old child, 4 months after second renal transplantation. Folman R, Arbus GS, Churchill B, Gaum L, Huber J. Clin Nephrol; 1978 Sep; 10(3):121-7. PubMed ID: 359209 [Abstract] [Full Text] [Related]
4. De novo hemolytic uremia syndrome: a rare adverse effect in renal transplant recipients immunosuppressed with cyclosporine. Lucca LJ, Ressurreiçao FA, Ferraz AS, Costa RS, Costa JA, Pisi TM, Alves MR. Transplant Proc; 1992 Dec; 24(6):3098-9. PubMed ID: 1466073 [No Abstract] [Full Text] [Related]
12. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy. Bren A, Pajek J, Grego K, Buturovic J, Ponikvar R, Lindic J, Knap B, Vizjak A, Ferluga D, Kandus A. Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494 [Abstract] [Full Text] [Related]
13. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Hill P, Goodship TH, Remuzzi G, International Registry of Recurrent and Familial HUS/TTP. Clin J Am Soc Nephrol; 2006 Jan; 1(1):88-99. PubMed ID: 17699195 [Abstract] [Full Text] [Related]